JuliaFoldiMD

PubMed

• Predicting clinical benefit from continuation of cyclin dependent kinase (CDK) 4/6 inhibitors beyond progression.
  Julia Foldi, Adam Brufsky> ;Annals of Translational Medicine. 2023 Jun 30
• 2 citations
  Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer.
  Julia Foldi, Anastasia Tsagianni, Max Salganik, Catherine A Schnabel, Adam Brufsky, G J van Londen, Lajos Pusztai, Tara Sanft> ;BMC Cancer. 2023 Jun 30
• 1 citations
  Pharmacology and pharmacokinetics of elacestrant.
  Jan H Beumer, Julia Foldi> ;Cancer Chemotherapy and Pharmacology. 2023 Aug 1
• 1 citations
  Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.
  Luca Licata, Giulia Viale, Mario Giuliano, Giuseppe Curigliano, Mariana Chavez-MacGregor, Julia Foldi, Oluchi Oke, Joseph Collins, Lucia Del Mastro, Fabio Puglisi, Fil...> ;NPJ Breast Cancer. 2023 Jun 8
• 1 citations
  Precision medicine for metastatic TNBC: the FUTURE is now.
  Julia Foldi, Charles E Geyer Jr> ;Cell Research. 2023 Jul 1
• Case report: abemaciclib-induced syndrome of inappropriate antidiuretic hormone (SIADH) without underlying kidney injury in a patient with early-stage estrogen recepto...
  Carleton, N., Foldi, J.> ;Frontiers in Medicine. 2023 Jan 1
• 4 citations
  Molecular differences between younger versus older ER-positive and HER2-negative breast cancers.
  Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michal Marczyk, Naing Lin Shan, Kim Blenman, Uwe Holtrich, Kevin Kalinsky, Funda Meric-Bernstam, Lajos Pusztai> ;NPJ Breast Cancer. 2022 Nov 7
• 1 citations
  Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.
  Julia Foldi, Adriana Kahn, Andrea Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar, Tristen Park, Ad...> ;Clinical Cancer Research. 2022 Sep 1
• 1 citations
  Cancer Relevance of Human Genes.
  Tao Qing, Hussein Mohsen, Vincent L Cannataro, Michal Marczyk, Mariya Rozenblit, Julia Foldi, Michael Murray, Jeffrey P Townsend, Yuval Kluger, Mark Gerstein, Lajos Pu...> ;Journal of the National Cancer Institute. 2022 Jul 11
• 12 citations
  Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.
  Kim R M Blenman, Michal Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea Silber, Den...> ;Clinical Cancer Research. 2022 Jun 13
• 6 citations
  A precision medicine approach to metabolic therapy for breast cancer in mice.
  Ngozi D Akingbesote, Aaron Norman, Wanling Zhu, Alexandra A Halberstam, Xinyi Zhang, Julia Foldi, Maryam B Lustberg, Rachel J Perry> ;Communications Biology. 2022 May 20
• 2 citations
  Comprehensive Analysis of Metabolic Isozyme Targets in Cancer.
  Michal Marczyk, Vignesh Gunasekharan, David Casadevall, Tao Qing, Julia Foldi, Raghav Sehgal, Naing Lin Shan, Kim R M Blenman, Tess A O'Meara, Sheila Umlauf, Yulia V S...> ;Cancer Research. 2022 May 3
• 1 citations
  Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
  Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Ch...> ;NPJ Breast Cancer. 2022 Feb 3
• 9 citations
  Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy.
  Julia Foldi, Mariya Rozenblit, Tristen S. Park, Christin A. Knowlton, Mehra Golshan, Meena S. Moran, Lajos Pusztai> ;Current Treatment Options in Oncology. 2021 Jul 2
• 2 citations
  Disease Progression in Children with Perinatal HIV Correlates with Increased PD-1+ CD8 T Cells that Coexpress Multiple Immune Checkpoints.
  Janki Tailor, Julia Foldi, Matthew Generoso, Bret McCarty, Aparna Alankar, Max Kilberg, Mussa Mwamzuka, Fatma Marshed, Aabid Ahmed, Mengling Liu, William Borkowsky, De...> ;The Journal of Infectious Diseases. 2021 Apr 17
• 29 citations
  Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
  Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal A. Fischbach, Justin Persico, Kerin B. Adelson, Anamika Katoch, Nina R. Horowitz, Donald R. Lann...> ;NPJ Breast Cancer. 2021 Feb 8
• 50 citations
  Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers
  Lajos Pusztai, Julia Foldi, Arjun Dhawan, Michael P. DiGiovanna, Eleftherios P. Mamounas> ;The Lancet. Oncology. 2019 Jul 1
• 4 citations
  Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade.
  David Casadevall, Xiaotong Li, Ryan L Powles, Vikram B. Wali, Natalia Buza, Vasiliki Pelekanou, Arjun Dhawan, Julia Foldi, Borbála Székely, Francesc López-Giráldez, Ch...> ;JCO Precision Oncology. 2019 May 10
• 17 citations
  Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular Tools
  Julia Foldi, Tess O'Meara, Michal Marczyk, Tara Sanft, Andrea Silber, Lajos Pusztai> ;Journal of Clinical Oncology. 2019 Apr 3
• 10 citations
  Cytomegalovirus resistance in CD34+ -selected hematopoietic cell transplant recipients.
  Seong Jin Kim, Yao-Ting Huang, Julia Foldi, Yeon Joo Lee, Molly Maloy, Sergio Giralt, Ann A. Jakubowski, Genovefa A. Papanicolaou> ;Transplant Infectious Disease. 2018 Jun 1
• 13 citations
  Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cycl...
  Julia Foldi, Sarah S. Mougalian, Andrea Silber, Donald R. Lannin, Brigid K. Killelea, Anees B. Chagpar, Nina R. Horowitz, Courtney Frederick, Lawrence Rispoli, Trisha ...> ;Breast Cancer Research and Treatment. 2018 Feb 2
• 20 citations
  HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
  Julia Foldi, Lina Kozhaya, Bret McCarty, Mussa Mwamzuka, Fatma Marshed, Tiina Ilmet, Max Kilberg, Adam Kravietz, Aabid Ahmed, William Borkowsky, Derya Unutmaz, Alka Kh...> ;The Journal of Infectious Diseases. 2017 Sep 15
• 25 citations
  Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation
  Yao-Ting Huang, Dionysios Neofytos, Julia Foldi, Seong Jin Kim, Molly Maloy, Dick Chung, Hugo Castro-Malaspina, Sergio Giralt, Esperanza B. Papadopoulos, Miguel-Angel ...> ;Biology of Blood and Marrow Transplantation. 2016 Aug 1
• 31 citations
  RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genes
  Julia Foldi, Yingli Shang, Baohong Zhao, Lionel B. Ivashkiv, Xiaoyu Hu> ;Protein & Cell. 2016 Feb 13
• 303 citations
  Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization.
  Haixia Xu, Jimmy Zhu, Sinead M. Smith, Julia Foldi, Baohong Zhao, Allen Y. Chung, Hasina H. Outtz, Jan Kitajewski, Chao Shi, Silvio Weber, Paul Saftig, Yueming Li, Kei...> ;Nature Immunology. 2012 Jul 1
• Join now to see all